Constar International Inc. (NASDAQ: CNST) today announced its financial results for the third quarter and nine months ended September 30, 2006. Third Quarter Results: Highlights when compared to the third quarter of 2005 include: Custom unit sales grew 19.6 percent. Gross margin improved to 8.3 percent from 5.4 percent. Operating income rose to $11.8 million compared to a loss of $17.1 million. Credit Agreement EBITDA increased 13.6 percent to $20.0 million. Income from continuing operations improved to $1.9 million compared to a loss of $23.6 million. �We are pleased with our continued improved performance in the quarter. Impressive execution of our strategy to grow custom sales, improve pricing, reduce costs, and improve working capital management yielded solid cash performance for the quarter," said Michael Hoffman, CEO and President of Constar. Consolidated net sales were $251.3 million in the third quarter of 2006 compared to $251.5 million in the third quarter of 2005. The slight decrease in consolidated net sales was driven by a decrease in unit volume, which was offset by the pass-through of higher resin costs to customers, favorable foreign currency translations, and the positive impact of the Company�s strategic value initiative plan. In the U.S., net sales of $198.2 million in the third quarter of 2006 remained consistent with net sales in the third quarter of 2005. Total U.S. unit volume decreased 4.2 percent over the third quarter of 2005. Custom unit volume growth was 19.6 percent, while conventional unit volume declined 8.7 percent compared to the third quarter of 2005. The impact of the net unit volume decrease on net sales was offset by the pass-through to customers of higher resin costs and the effect of the Company�s strategic value initiative plan. In Europe, net sales were $53.1 million in the third quarter of 2006 compared to $53.3 million in the third quarter of 2005. The slight decrease in European net sales in the third quarter of 2006 was primarily due to a decline in conventional unit volume of 10.0 percent compared to the third quarter of 2005, offset by favorable foreign currency translations and the pass-through of higher resin costs to customers. U.S. net sales accounted for 78.9 percent of net sales in the third quarter of 2006 compared to 78.8 percent of net sales in the third quarter of 2005. Gross profit increased $7.2 million to $20.8 million in the third quarter of 2006 from $13.6 million in the third quarter of 2005. Gross profit as a percentage of net sales increased to 8.3 percent from 5.4 percent in the 2005 third quarter. The increase reflects improved product and customer mix, lower costs, benefits from the Company�s strategic value initiative plan, reduced depreciation expense, lower property and other non-income related taxes, a reduction in customer rebates and improved operating efficiencies in U.S. manufacturing operations. Selling and administrative expenses increased by $0.1 million to $6.9 million in the third quarter of 2006 from $6.8 million in the third quarter of 2005. This modest increase primarily relates to increased compensation expense of $1.0 million, offset by an adjustment of $0.6 million related to incentive compensation and decreased legal and bad debt expense. In the third quarter of 2005, the Company recorded a non-cash asset impairment charge of $22.2 million to write down to fair value the carrying value of assets used in its European operations. Operating income rose to $11.8 million in the 2006 third quarter compared to a loss of $17.1 million in the third quarter of 2005. The improvement primarily reflects the increase in gross profit and the absence of impairment charges in 2006 compared to an impairment charge of $22.2 million in 2005. Interest expense increased $0.6 million to $10.4 million in the third quarter of 2006 from $9.8 million in the third quarter of 2005 as a result of a higher effective interest rate partially offset by lower average borrowings. Other income increased to $0.6 million in the third quarter of 2006 compared to the third quarter of 2005. The income in 2006 primarily resulted from the positive impact of changes in foreign currency translation rates on intra-company balances and from royalty income. Net income was $1.4 million in the third quarter of 2006, or $0.11 income per basic and diluted share, compared to a net loss of $23.5 million, or $1.93 loss per basic and diluted share, in the third quarter of 2005. Credit Agreement EBITDA in the third quarter of 2006 increased by $2.4 million, or 13.6 percent, to $20.0 million from $17.6 million in the third quarter of 2005. This increase was primarily due to a higher gross profit excluding depreciation expense, partially offset by increased operating expenses, excluding asset impairment charges. EBITDA is defined by the Company as net income (loss) before interest expense, provision for income taxes, depreciation and amortization. The Company's Credit Agreement adjusts EBITDA for certain items. In the third quarter of 2006, these adjustments amounted to $0.6 million. In the third quarter of 2005, these adjustments were $16.9 million. Credit Agreement EBITDA is not a GAAP-defined measure and may not be comparable to adjusted EBITDA as defined by other companies. Management believes that investors, analysts and other interested parties view our ability to generate Credit Agreement EBITDA as an important indicator of our operating performance. Management also believes that Credit Agreement EBITDA is a useful measure in understanding trends because it eliminates various non-operational and non-recurring items. In addition, Credit Agreement EBITDA facilitates comparisons to operating performance in prior periods, and is used by the Company in setting incentive plan targets. Investors are urged to take into account GAAP measures in evaluating the Company, and to review the reconciliation of Credit Agreement EBITDA to net income (loss) in the attached unaudited consolidated statements of operations. For the three months ended September 30, 2006, net cash provided by operating activities was $37.5 million, and net cash used in investing activities was $4.4 million. First Nine Months Results: Consolidated net sales grew by $9.3 million to $735.5 million in the first nine months of 2006 from $726.2 million in the same period last year. The increase was primarily driven by the pass- through of higher resin costs to customers, an increase in custom unit volume and the impact of the Company�s strategic value initiative plan, partially offset by unfavorable foreign currency translations. In the U.S., net sales increased $17.1 million to $586.3 million in the first nine months of 2006 from $569.2 million in the first nine months of 2005. The increase was primarily driven by the pass-through of higher resin costs to customers, an increase in custom unit volume and the impact of the Company�s strategic value initiative plan. Total U.S. unit volume increased 0.7 percent in the first nine months of 2006 over the same period last year. This increase reflects custom unit volume growth of 30.9 percent and a 4.9 percent decrease in conventional unit volume. In Europe, net sales decreased $7.8 million to $149.2 million in the nine months ended September 30, 2006 from $157.0 million in the first nine months of 2005. The decrease was due to the weakening of the British Pound and Euro against the U.S. Dollar, and a 3.5 percent decrease in unit volume. U.S. net sales accounted for 79.7 percent of net sales in the first nine months of 2006 compared to 78.4 percent of net sales in the same period last year. Gross profit increased $24.2 million to $54.5 million for the first nine months of 2006 from $30.3 million in the first nine months of 2005. Gross profit as a percentage of net sales in the first nine months of 2006 increased to 7.4 percent from 4.2 percent in the same period last year. The increase reflects improved customer and product mix, lower costs, the impact of the Company�s strategic value initiative plan, lower depreciation expense and improved operating efficiencies in U.S. manufacturing operations, partially offset by a decrease in gross profit, excluding depreciation, in our European operations. Selling and administrative expenses were $22.8 million in the first nine months of 2006 compared to $19.0 million in the same period last year. The increase primarily reflects a $1.7 million increase in compensation expense, $1.3 million for additional audit and Sarbanes-Oxley related expenses, $1.3 million of increased other expenses and $1.0 million in higher legal fees, offset by a $1.5 million reduction in bad debt expense. In connection with its February 2005 refinancing, the Company repaid amounts outstanding under its former revolving loan facility and two term loans. As a result of these repayments the Company wrote off approximately $6.5 million of the remainder of the deferred financing costs related to those three facilities and incurred prepayment penalties of approximately $3.5 million. In the nine months ended September 30, 2006, the Company recorded a non-cash asset impairment charge of $0.9 million to write down the carrying value of an asset to fair value. In the nine months ended September 30, 2005, the Company recorded a non-cash asset impairment charge of $22.2 million to write down the carrying value of assets used in its European operations to fair value. Operating income was $25.6 million in the nine months ended September 30, 2006 compared to an operating loss of $25.8 million in the nine months ended September 30, 2005. This increase in operating income primarily relates to the improved operating performance described above, and the absence in 2006 of $22.2 million in impairment charges, a $10.0 million write-off of deferred financing costs and prepayment penalties associated with the 2005 refinancing. Interest expense increased $2.3 million to $31.1 million in the nine months ended September 30, 2006 from $28.8 million in the nine months ended September 30, 2005 as a result of a higher effective interest rate and higher average borrowings. In the first nine months of 2006, the Company reported other income of $1.8 million compared to other expense of $0.4 million in the first nine months of 2005. The income in 2006 was primarily from the positive impact of changes in the foreign currency translation rates of intra-company balances and royalty income. Net loss in the nine months ended September 30, 2006 was $4.8 million, or $0.39 loss per basic and diluted share, compared to a net loss of $51.2 million, or $4.22 loss per basic and diluted share, in the nine months ended September 30, 2005. Credit Agreement EBITDA in the nine months ended September 30, 2006 increased by 24.5 percent to $54.9 million from $44.1 million in the first nine months of last year. This increase was primarily due to a higher gross profit excluding depreciation expense, partially offset by increased operating expenses, excluding asset impairment charges. In the nine months ended September 30, 2006, Credit Agreement adjustments to EBITDA were $2.2 million. In the nine months ended September 30, 2005, adjustments were $29.4 million, which included the write-off of deferred financing costs of $10.0 million and the asset impairment charge. For the nine months ended September 30, 2006, net cash provided by operating activities was $37.9 million, and net cash used in investing activities was $17.1 million. Conference Call, Web Cast Information The Company will hold a conference call on Tuesday, November 14, 2006, at 9:00 a.m. ET to discuss this news release. Forward-looking and other material information will be discussed on this conference call. The dial-in numbers for the conference call are (800) 810-0924 (domestic callers) or (913) 981-4900 (international callers). The conference call will also be broadcast live over the internet and can be accessed via the Company's website: www.constar.net. Please log on approximately 15 minutes prior to the call to register and download any necessary audio software. A replay of the broadcast will be available from 1:00 p.m. ET that day until midnight on Tuesday, November 21, 2006 and can be accessed via telephone by dialing (888) 203-1112 (domestic callers) or (719) 457-0820 (international callers) and entering passcode 4502547, or via the web at www.constar.net where it will be archived. Cautionary Note Regarding Forward-Looking Statements Except for historical information, all information in this news release consists of forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve a number of risks, uncertainties and other factors, which may cause the actual results to be materially different from those expressed or implied in the forward-looking statements. Important factors that could cause the statements made in this news release or the actual results of operations or financial condition of the Company to differ include the Company�s relationship with its largest customer PepsiCo, the success of the Company�s strategic pricing initiative plan and the Company�s ability to secure new business, expand sales of custom products and improve the operating performance of its European business. Other important factors are discussed under the caption �Risk Factors� in the Company�s Form 10-K Annual Report for the year ended December 31, 2005 and in subsequent filings with the Securities and Exchange Commission made prior to, on or after the date hereof. The Company does not intend to review or revise any particular forward-looking statement in light of future events. About Constar Philadelphia-based Constar is a leading global producer of PET (polyethylene terephthalate) plastic containers for food, soft drinks and water. The Company provides full-service packaging solutions, from product design and engineering, to ongoing customer support. Its customers include many of the world's leading branded consumer products companies. CONSTAR INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS COMPARISON (in thousands, except per share data) (Unaudited) Three months ended Nine months ended September 30, September 30, 2006� 2005� 2006� 2005� Net customer sales $ 250,466� $ 250,285� $ 732,437� $ 722,766� Net affiliate sales � 818� � 1,211� � 3,030� � 3,424� Net sales 251,284� 251,496� 735,467� 726,190� Cost of products sold, excluding depreciation 222,946� 226,686� 654,542� 662,145� Depreciation � 7,579� � 11,220� � 26,417� � 33,747� Gross profit � 20,759� � 13,590� � 54,508� � 30,298� Selling and administrative expenses 6,939� 6,778� 22,769� 19,023� Research and technology expenses 1,671� 1,614� 4,697� 4,660� Write-off of deferred financing costs -� -� -� 10,025� Asset impairment charges -� 22,200� 870� 22,200� Provision for restructuring � 365� � 60� � 591� � 170� Total operating expenses � 8,975� � 30,652� � 28,927� � 56,078� Operating income (loss) 11,784� (17,062) 25,581� (25,780) Interest expense 10,422� 9,762� 31,072� 28,766� Other (income) expense, net � (584) � 34� � (1,774) � 383� Income (loss) from continuing operations before income taxes 1,946� (26,858) (3,717) (54,929) (Provision for) benefit from income taxes � -� � 3,260� � -� � 3,414� Income (loss) from continuing operations 1,946� (23,598) (3,717) (51,515) Income (loss) from discontinued operations, net of taxes � (563) � 131� � (1,074) � 299� Net Income (loss) $ 1,383� $ (23,467) $ (4,791) $ (51,216) � Basic earnings (loss) per common share: Continuing operations $ 0.16� $ (1.94) $ (0.30) $ (4.25) Discontinued operations � (0.05) � 0.01� � (0.09) � 0.03� Net income(loss) per share $ 0.11� $ (1.93) $ (0.39) $ (4.22) � Diluted earnings (loss) per common share: Continuing operations $ 0.15� $ (1.94) $ (0.30) $ (4.25) Discontinued operations � (0.04) � 0.01� � (0.09) � 0.03� Net income(loss) per share $ 0.11� $ (1.93) $ (0.39) $ (4.22) Weighted average common shares outstanding: Basic � 12,235� � 12,157� � 12,214� � 12,135� Diluted � 12,589� � 12,157� � 12,214� � 12,135� � Three months ended Nine months ended September 30, September 30, 2006� 2005� 2006� 2005� � Reconciliation of net income (loss) to Credit Agreement EBITDA: Net loss $ 1,383� $ (23,467) $ (4,791) $ (51,216) Add back: Interest expense 10,422� 9,762� 31,072� 28,766� Taxes -� (3,260) -� (3,414) Depreciation � 7,579� � 11,220� � 26,417� � 33,747� EBITDA 19,384� (5,745) 52,698� 7,883� Other adjustments under Credit Agreement � 639� � 23,374� � 2,179� � 36,223� Credit Agreement EBITDA $ 20,023� $ 17,629� $ 54,877� $ 44,106� � SELECTED BALANCE SHEET DATA September 30, September 30, 2006� 2005� Cash and cash equivalents $ 17,463� $ 8,087� Debt: Revolver Loan $ -� $ 3,658� Other $ -� $ 1,525� Senior Notes $ 220,000� $ 220,000� Senior Subordinated Notes $ 175,000� $ 175,000� Constar International Inc. (NASDAQ: CNST) today announced its financial results for the third quarter and nine months ended September 30, 2006. Third Quarter Results: Highlights when compared to the third quarter of 2005 include: Custom unit sales grew 19.6 percent. Gross margin improved to 8.3 percent from 5.4 percent. Operating income rose to $11.8 million compared to a loss of $17.1 million. Credit Agreement EBITDA increased 13.6 percent to $20.0 million. Income from continuing operations improved to $1.9 million compared to a loss of $23.6 million. "We are pleased with our continued improved performance in the quarter. Impressive execution of our strategy to grow custom sales, improve pricing, reduce costs, and improve working capital management yielded solid cash performance for the quarter," said Michael Hoffman, CEO and President of Constar. Consolidated net sales were $251.3 million in the third quarter of 2006 compared to $251.5 million in the third quarter of 2005. The slight decrease in consolidated net sales was driven by a decrease in unit volume, which was offset by the pass-through of higher resin costs to customers, favorable foreign currency translations, and the positive impact of the Company's strategic value initiative plan. In the U.S., net sales of $198.2 million in the third quarter of 2006 remained consistent with net sales in the third quarter of 2005. Total U.S. unit volume decreased 4.2 percent over the third quarter of 2005. Custom unit volume growth was 19.6 percent, while conventional unit volume declined 8.7 percent compared to the third quarter of 2005. The impact of the net unit volume decrease on net sales was offset by the pass-through to customers of higher resin costs and the effect of the Company's strategic value initiative plan. In Europe, net sales were $53.1 million in the third quarter of 2006 compared to $53.3 million in the third quarter of 2005. The slight decrease in European net sales in the third quarter of 2006 was primarily due to a decline in conventional unit volume of 10.0 percent compared to the third quarter of 2005, offset by favorable foreign currency translations and the pass-through of higher resin costs to customers. U.S. net sales accounted for 78.9 percent of net sales in the third quarter of 2006 compared to 78.8 percent of net sales in the third quarter of 2005. Gross profit increased $7.2 million to $20.8 million in the third quarter of 2006 from $13.6 million in the third quarter of 2005. Gross profit as a percentage of net sales increased to 8.3 percent from 5.4 percent in the 2005 third quarter. The increase reflects improved product and customer mix, lower costs, benefits from the Company's strategic value initiative plan, reduced depreciation expense, lower property and other non-income related taxes, a reduction in customer rebates and improved operating efficiencies in U.S. manufacturing operations. Selling and administrative expenses increased by $0.1 million to $6.9 million in the third quarter of 2006 from $6.8 million in the third quarter of 2005. This modest increase primarily relates to increased compensation expense of $1.0 million, offset by an adjustment of $0.6 million related to incentive compensation and decreased legal and bad debt expense. In the third quarter of 2005, the Company recorded a non-cash asset impairment charge of $22.2 million to write down to fair value the carrying value of assets used in its European operations. Operating income rose to $11.8 million in the 2006 third quarter compared to a loss of $17.1 million in the third quarter of 2005. The improvement primarily reflects the increase in gross profit and the absence of impairment charges in 2006 compared to an impairment charge of $22.2 million in 2005. Interest expense increased $0.6 million to $10.4 million in the third quarter of 2006 from $9.8 million in the third quarter of 2005 as a result of a higher effective interest rate partially offset by lower average borrowings. Other income increased to $0.6 million in the third quarter of 2006 compared to the third quarter of 2005. The income in 2006 primarily resulted from the positive impact of changes in foreign currency translation rates on intra-company balances and from royalty income. Net income was $1.4 million in the third quarter of 2006, or $0.11 income per basic and diluted share, compared to a net loss of $23.5 million, or $1.93 loss per basic and diluted share, in the third quarter of 2005. Credit Agreement EBITDA in the third quarter of 2006 increased by $2.4 million, or 13.6 percent, to $20.0 million from $17.6 million in the third quarter of 2005. This increase was primarily due to a higher gross profit excluding depreciation expense, partially offset by increased operating expenses, excluding asset impairment charges. EBITDA is defined by the Company as net income (loss) before interest expense, provision for income taxes, depreciation and amortization. The Company's Credit Agreement adjusts EBITDA for certain items. In the third quarter of 2006, these adjustments amounted to $0.6 million. In the third quarter of 2005, these adjustments were $16.9 million. Credit Agreement EBITDA is not a GAAP-defined measure and may not be comparable to adjusted EBITDA as defined by other companies. Management believes that investors, analysts and other interested parties view our ability to generate Credit Agreement EBITDA as an important indicator of our operating performance. Management also believes that Credit Agreement EBITDA is a useful measure in understanding trends because it eliminates various non-operational and non-recurring items. In addition, Credit Agreement EBITDA facilitates comparisons to operating performance in prior periods, and is used by the Company in setting incentive plan targets. Investors are urged to take into account GAAP measures in evaluating the Company, and to review the reconciliation of Credit Agreement EBITDA to net income (loss) in the attached unaudited consolidated statements of operations. For the three months ended September 30, 2006, net cash provided by operating activities was $37.5 million, and net cash used in investing activities was $4.4 million. First Nine Months Results: Consolidated net sales grew by $9.3 million to $735.5 million in the first nine months of 2006 from $726.2 million in the same period last year. The increase was primarily driven by the pass- through of higher resin costs to customers, an increase in custom unit volume and the impact of the Company's strategic value initiative plan, partially offset by unfavorable foreign currency translations. In the U.S., net sales increased $17.1 million to $586.3 million in the first nine months of 2006 from $569.2 million in the first nine months of 2005. The increase was primarily driven by the pass-through of higher resin costs to customers, an increase in custom unit volume and the impact of the Company's strategic value initiative plan. Total U.S. unit volume increased 0.7 percent in the first nine months of 2006 over the same period last year. This increase reflects custom unit volume growth of 30.9 percent and a 4.9 percent decrease in conventional unit volume. In Europe, net sales decreased $7.8 million to $149.2 million in the nine months ended September 30, 2006 from $157.0 million in the first nine months of 2005. The decrease was due to the weakening of the British Pound and Euro against the U.S. Dollar, and a 3.5 percent decrease in unit volume. U.S. net sales accounted for 79.7 percent of net sales in the first nine months of 2006 compared to 78.4 percent of net sales in the same period last year. Gross profit increased $24.2 million to $54.5 million for the first nine months of 2006 from $30.3 million in the first nine months of 2005. Gross profit as a percentage of net sales in the first nine months of 2006 increased to 7.4 percent from 4.2 percent in the same period last year. The increase reflects improved customer and product mix, lower costs, the impact of the Company's strategic value initiative plan, lower depreciation expense and improved operating efficiencies in U.S. manufacturing operations, partially offset by a decrease in gross profit, excluding depreciation, in our European operations. Selling and administrative expenses were $22.8 million in the first nine months of 2006 compared to $19.0 million in the same period last year. The increase primarily reflects a $1.7 million increase in compensation expense, $1.3 million for additional audit and Sarbanes-Oxley related expenses, $1.3 million of increased other expenses and $1.0 million in higher legal fees, offset by a $1.5 million reduction in bad debt expense. In connection with its February 2005 refinancing, the Company repaid amounts outstanding under its former revolving loan facility and two term loans. As a result of these repayments the Company wrote off approximately $6.5 million of the remainder of the deferred financing costs related to those three facilities and incurred prepayment penalties of approximately $3.5 million. In the nine months ended September 30, 2006, the Company recorded a non-cash asset impairment charge of $0.9 million to write down the carrying value of an asset to fair value. In the nine months ended September 30, 2005, the Company recorded a non-cash asset impairment charge of $22.2 million to write down the carrying value of assets used in its European operations to fair value. Operating income was $25.6 million in the nine months ended September 30, 2006 compared to an operating loss of $25.8 million in the nine months ended September 30, 2005. This increase in operating income primarily relates to the improved operating performance described above, and the absence in 2006 of $22.2 million in impairment charges, a $10.0 million write-off of deferred financing costs and prepayment penalties associated with the 2005 refinancing. Interest expense increased $2.3 million to $31.1 million in the nine months ended September 30, 2006 from $28.8 million in the nine months ended September 30, 2005 as a result of a higher effective interest rate and higher average borrowings. In the first nine months of 2006, the Company reported other income of $1.8 million compared to other expense of $0.4 million in the first nine months of 2005. The income in 2006 was primarily from the positive impact of changes in the foreign currency translation rates of intra-company balances and royalty income. Net loss in the nine months ended September 30, 2006 was $4.8 million, or $0.39 loss per basic and diluted share, compared to a net loss of $51.2 million, or $4.22 loss per basic and diluted share, in the nine months ended September 30, 2005. Credit Agreement EBITDA in the nine months ended September 30, 2006 increased by 24.5 percent to $54.9 million from $44.1 million in the first nine months of last year. This increase was primarily due to a higher gross profit excluding depreciation expense, partially offset by increased operating expenses, excluding asset impairment charges. In the nine months ended September 30, 2006, Credit Agreement adjustments to EBITDA were $2.2 million. In the nine months ended September 30, 2005, adjustments were $29.4 million, which included the write-off of deferred financing costs of $10.0 million and the asset impairment charge. For the nine months ended September 30, 2006, net cash provided by operating activities was $37.9 million, and net cash used in investing activities was $17.1 million. Conference Call, Web Cast Information The Company will hold a conference call on Tuesday, November 14, 2006, at 9:00 a.m. ET to discuss this news release. Forward-looking and other material information will be discussed on this conference call. The dial-in numbers for the conference call are (800) 810-0924 (domestic callers) or (913) 981-4900 (international callers). The conference call will also be broadcast live over the internet and can be accessed via the Company's website: www.constar.net. Please log on approximately 15 minutes prior to the call to register and download any necessary audio software. A replay of the broadcast will be available from 1:00 p.m. ET that day until midnight on Tuesday, November 21, 2006 and can be accessed via telephone by dialing (888) 203-1112 (domestic callers) or (719) 457-0820 (international callers) and entering passcode 4502547, or via the web at www.constar.net where it will be archived. Cautionary Note Regarding Forward-Looking Statements Except for historical information, all information in this news release consists of forward-looking statements within the meaning of the federal securities laws. These forward-looking statements involve a number of risks, uncertainties and other factors, which may cause the actual results to be materially different from those expressed or implied in the forward-looking statements. Important factors that could cause the statements made in this news release or the actual results of operations or financial condition of the Company to differ include the Company's relationship with its largest customer PepsiCo, the success of the Company's strategic pricing initiative plan and the Company's ability to secure new business, expand sales of custom products and improve the operating performance of its European business. Other important factors are discussed under the caption "Risk Factors" in the Company's Form 10-K Annual Report for the year ended December 31, 2005 and in subsequent filings with the Securities and Exchange Commission made prior to, on or after the date hereof. The Company does not intend to review or revise any particular forward-looking statement in light of future events. About Constar Philadelphia-based Constar is a leading global producer of PET (polyethylene terephthalate) plastic containers for food, soft drinks and water. The Company provides full-service packaging solutions, from product design and engineering, to ongoing customer support. Its customers include many of the world's leading branded consumer products companies. -0- *T CONSTAR INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS COMPARISON (in thousands, except per share data) (Unaudited) Three months ended Nine months ended September 30, September 30, ------------------- ------------------- 2006 2005 2006 2005 --------- --------- --------- --------- Net customer sales $250,466 $250,285 $732,437 $722,766 Net affiliate sales 818 1,211 3,030 3,424 --------- --------- --------- --------- Net sales 251,284 251,496 735,467 726,190 Cost of products sold, excluding depreciation 222,946 226,686 654,542 662,145 Depreciation 7,579 11,220 26,417 33,747 --------- --------- --------- --------- Gross profit 20,759 13,590 54,508 30,298 --------- --------- --------- --------- Selling and administrative expenses 6,939 6,778 22,769 19,023 Research and technology expenses 1,671 1,614 4,697 4,660 Write-off of deferred financing costs - - - 10,025 Asset impairment charges - 22,200 870 22,200 Provision for restructuring 365 60 591 170 --------- --------- --------- --------- Total operating expenses 8,975 30,652 28,927 56,078 --------- --------- --------- --------- Operating income (loss) 11,784 (17,062) 25,581 (25,780) Interest expense 10,422 9,762 31,072 28,766 Other (income) expense, net (584) 34 (1,774) 383 --------- --------- --------- --------- Income (loss) from continuing operations before income taxes 1,946 (26,858) (3,717) (54,929) (Provision for) benefit from income taxes - 3,260 - 3,414 --------- --------- --------- --------- Income (loss) from continuing operations 1,946 (23,598) (3,717) (51,515) Income (loss) from discontinued operations, net of taxes (563) 131 (1,074) 299 --------- --------- --------- --------- Net Income (loss) $ 1,383 $(23,467) $ (4,791) $(51,216) ========= ========= ========= ========= Basic earnings (loss) per common share: Continuing operations $ 0.16 $ (1.94) $ (0.30) $ (4.25) Discontinued operations (0.05) 0.01 (0.09) 0.03 --------- --------- --------- --------- Net income(loss) per share $ 0.11 $ (1.93) $ (0.39) $ (4.22) ========= ========= ========= ========= Diluted earnings (loss) per common share: Continuing operations $ 0.15 $ (1.94) $ (0.30) $ (4.25) Discontinued operations (0.04) 0.01 (0.09) 0.03 --------- --------- --------- --------- Net income(loss) per share $ 0.11 $ (1.93) $ (0.39) $ (4.22) ========= ========= ========= ========= Weighted average common shares outstanding: Basic 12,235 12,157 12,214 12,135 ========= ========= ========= ========= Diluted 12,589 12,157 12,214 12,135 ========= ========= ========= ========= Three months ended Nine months ended September 30, September 30, ------------------- ------------------- 2006 2005 2006 2005 --------- --------- --------- --------- Reconciliation of net income (loss) to Credit Agreement EBITDA: Net loss $ 1,383 $(23,467) $ (4,791) $(51,216) Add back: Interest expense 10,422 9,762 31,072 28,766 Taxes - (3,260) - (3,414) Depreciation 7,579 11,220 26,417 33,747 --------- --------- --------- --------- EBITDA 19,384 (5,745) 52,698 7,883 Other adjustments under Credit Agreement 639 23,374 2,179 36,223 --------- --------- --------- --------- Credit Agreement EBITDA $ 20,023 $ 17,629 $ 54,877 $ 44,106 ========= ========= ========= ========= *T -0- *T ------------------------------------------ SELECTED BALANCE SHEET DATA September 30, September 30, ------------------------------------------ 2006 2005 ------------- ------------- Cash and cash equivalents $ 17,463 $ 8,087 Debt: Revolver Loan $ - $ 3,658 Other $ - $ 1,525 Senior Notes $ 220,000 $ 220,000 Senior Subordinated Notes $ 175,000 $ 175,000 *T
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024 Plus de graphiques de la Bourse Constellation Pharmaceut...
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024 Plus de graphiques de la Bourse Constellation Pharmaceut...